Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
$351M |
| 2 |
Netflix
NFLX
|
$343M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
$293M |
| 4 |
Nike
NKE
|
$186M |
| 5 |
Delta Air Lines
DAL
|
$177M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$1.33B |
| 2 |
Tesla
TSLA
|
$344M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$306M |
| 4 |
NVIDIA
NVDA
|
$281M |
| 5 |
Boeing
BA
|
$251M |
Sector Composition
| 1 | Technology | 19.27% |
| 2 | Healthcare | 18.45% |
| 3 | Consumer Discretionary | 12.35% |
| 4 | Consumer Staples | 10.15% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Petrobras
PBR
$78.7B
| $51.6M | 0.09% |
3,444,500
-658,700
| -16% | -$9.87M |
|
252
BioMarin Pharmaceuticals
BMRN
$11.1B
| $51.5M | 0.09% |
581,771
-150,867
| -21% | -$13.3M |
|
253
argenx
ARGX
$45.9B
| $51.5M | 0.09% |
104,700
-9,300
| -8% | -$4.57M |
|
254
Travelers Companies
TRV
$62B
| $51.5M | 0.09% |
315,172
+211,700
| +205% | +$34.6M |
|
|
SWAV
255
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $51.1M | 0.09% |
256,600
+53,800
| +27% | +$10.7M |
|
256
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$13.7B
| $50.6M | 0.09% |
505,400
+182,000
| +56% | +$18.2M |
|
257
iShares Treasury Floating Rate Bond ETF
TFLO
$6.71B
| $50.5M | 0.09% |
995,900
+301,100
| +43% | +$15.3M |
|
258
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$6.25B
| $50.5M | 0.09% |
504,200
+153,600
| +44% | +$15.4M |
|
259
iShares Short Treasury Bond ETF
SHV
$20.8B
| $50.5M | 0.09% |
456,900
+139,800
| +44% | +$15.4M |
|
260
iShares Ultra Short Duration Bond Active ETF
ICSH
$6.18B
| $50.5M | 0.09% |
1,001,800
+341,500
| +52% | +$17.2M |
|
261
iShares 0-3 Month Treasury Bond ETF
SGOV
$56B
| $50.5M | 0.09% |
501,300
+153,900
| +44% | +$15.5M |
|
262
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$42B
| $50.5M | 0.09% |
549,600
+166,900
| +44% | +$15.3M |
|
263
JPMorgan Ultra-Short Income ETF
JPST
$33B
| $50.4M | 0.09% |
1,005,200
+364,800
| +57% | +$18.3M |
|
264
PGIM Ultra Short Bond ETF
PULS
$12.3B
| $50.4M | 0.09% |
1,018,300
+367,500
| +56% | +$18.2M |
|
265
Crown Castle
CCI
$41.9B
| $50.3M | 0.09% |
546,603
+310,500
| +132% | +$28.6M |
|
266
WisdomTree Floating Rate Treasury Fund
USFR
$18.9B
| $50.2M | 0.09% |
997,900
+302,200
| +43% | +$15.2M |
|
267
First Trust Enhanced Short Maturity ETF
FTSM
$6.16B
| $50.2M | 0.09% |
844,300
+256,700
| +44% | +$15.3M |
|
268
Snap-on
SNA
$17.1B
| $50.1M | 0.09% |
196,300
+11,600
| +6% | +$2.96M |
|
269
Nutanix
NTNX
$18.7B
| $50M | 0.09% |
1,434,393
-298,207
| -17% | -$10.4M |
|
270
Takeda Pharmaceutical
TAK
$48.6B
| $50M | 0.09% |
3,230,900
-419,100
| -11% | -$6.48M |
|
271
IonQ
IONQ
$12.4B
| $49.9M | 0.09% |
3,356,400
+1,224,500
| +57% | +$18.2M |
|
272
iShares Short Maturity Bond ETF
NEAR
$3.51B
| $49.7M | 0.08% |
996,700
+350,100
| +54% | +$17.5M |
|
273
SPDR Bloomberg 3-12 Month T-Bill ETF
BILS
$3.84B
| $49.5M | 0.08% |
498,100
+173,600
| +53% | +$17.3M |
|
274
Pacira BioSciences
PCRX
$1.19B
| $49.5M | 0.08% |
1,613,997
+39,300
| +2% | +$1.21M |
|
275
Sturm, Ruger & Co
RGR
$572M
| $49.4M | 0.08% |
948,276
+16,900
| +2% | +$881K |
|